News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Implant Sciences Corporation Says CEO Retires, Names Replacement
September 28, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Sept 27 (Reuters) - Implant Sciences Corp (IMX.A: Quote, Profile, Research) said Anthony Armini, its chief executive officer and president, has retired and will be replaced by Chief Operating Officer Phillip Thomas.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Layoff Tracker
Gilead Lays Off Employees at California Headquarters
April 3, 2026
·
45 min read
·
BioSpace Editorial Staff
Manufacturing
BioNTech Starts Shuttering Singapore mRNA Manufacturing Site Amid Pipeline Pivot
April 3, 2026
·
2 min read
·
Nick Paul Taylor
Tariffs
Trump Hits Drugmakers With 100% Tariff but Carve-outs Soften the Blow
April 3, 2026
·
2 min read
·
Nick Paul Taylor
Mergers & acquisitions
Pharma’s M&A Train Is on Track for Record Highs With More Deals To Come: Analysts
April 3, 2026
·
3 min read
·
Annalee Armstrong
